Skip to main content
FDA on pace for record year of generic approvals

The approval of 633 abbreviated new drug applications so far in fiscal 2017 has put the FDA on pace to exceed last year's 651 approvals. The agency has said it still needs to address the speed of reviews for complex generics and find ways to reduce the number of review cycles.

Full Story: